Clinical Research Advantage entered the industry of Medical Labs in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6215110, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.
To acquire more information, please contact Michel Sanchez, Manager by calling (702) 982-0749 during business hours. You can also write to the business’ Single Location at 2481 Professional Court, Las Vegas, Nevada NV 89128. You can also visit the company’s website at crastudies.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Clinical Research Advantage |
Representative: | Michel Sanchez, Manager |
Place of Business: | 2481 Professional Court, Las Vegas, NV 89128 |
Contact Number: | (702) 982-0749 |
Website: | crastudies.com |
Type of Service: | Medical Labs |
SIC Number: | 8071 |
NAICS Number: | 6215110 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Income/Year: | $1.000.000 to $2.499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Clinical Research Advantage is a company operating from Clark, Nevada providing professional Medical Labs and relevant B2C variables. It was founded in 0 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 6215110 as Medical Labs.
With a current employee count of 1 to 4, Clinical Research Advantage has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Michel Sanchez, Manager at (702) 982-0749 for related queries, or to locate its Single Location using the coordinates 36.2052,-115.25475.
The Single Location can also be found at the street address 2481 Professional Court in Las Vegas, Nevada 89128 and can be engaged online through the company website at crastudies.com, the company Twitter , and Facebook page .